2023
DOI: 10.1503/cmaj.221438
|View full text |Cite
|
Sign up to set email alerts
|

A pragmatic approach to the management of menopause

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 52 publications
1
5
0
Order By: Relevance
“…We agree with Lega and colleagues 1 that menopausal hormone therapy (MHT) has been shown in randomized controlled trials (RCTs) to be effective and safe for treating problematic vasomotor symptoms related to menopause. We also agree that treating menopausal vasomotor symptoms is important to decrease later life risks for heart disease and osteoporotic fracture.…”
supporting
confidence: 62%
See 1 more Smart Citation
“…We agree with Lega and colleagues 1 that menopausal hormone therapy (MHT) has been shown in randomized controlled trials (RCTs) to be effective and safe for treating problematic vasomotor symptoms related to menopause. We also agree that treating menopausal vasomotor symptoms is important to decrease later life risks for heart disease and osteoporotic fracture.…”
supporting
confidence: 62%
“…For women or people born with ovaries who do not wish to, or cannot, take estrogen-based therapy for vasomotor symptoms, oral micronized progesterone has been shown to be both effective and safe in menopause in an RCT, but this practical information was not provided in Lega and colleagues’ review. 1 , 2 …”
mentioning
confidence: 99%
“…More recently, a review in the Canadian Medical Association Journal entitled “A Pragmatic Approach to the Management of Menopause,” reported that, despite early concerns, increasing evidence shows a possible reduction in coronary artery disease with MHT among patients who start MHT before age 60 years or within 10 years of menopause. 24 Furthermore, they note that both RCTs and observational studies consistently show that an association exists between MHT and reductions of coronary artery disease events among women. Lega et al.…”
Section: Moving Forwardmentioning
confidence: 99%
“…note that the metabolic benefits of MHT include an improvement in lipid profile (an increase in high-density lipoprotein and a decrease in low-density lipoprotein) and that some studies have suggested an improvement in insulin sensitivity with a reduction in the risk of diabetes. 24 …”
Section: Moving Forwardmentioning
confidence: 99%
“…Additionally, the potential negative consequences associated with extended estrogen therapy encompass vaginal hemorrhage, perineal pain, and the development of breast cancer. 13,14,15 Consequently, further research is required to identify alternative agents capable of producing similar advantageous outcomes to estrogen with minimal or no adverse effects.…”
mentioning
confidence: 99%